leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 11:47:00 - browse：46

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： 2024 GOP presidential candidates spar over abortion in debate

WSS

EU regulator recommends expanding Mounjaro approval to obesity

Why doctors need education on FDA device approval process

Apellis safety probe of eye disease drug centers on injection needle

Medicare explains how it will choose drugs for negotiation

Complete sequence of Y chromosome published for first time

2024 GOP presidential candidates spar over abortion in debate

entertainment

leisure time

knowledge

Activists slam private health insurers over coverage restrictions

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Walensky prepares to leave CDC — and Congress — behind

What AAP's gender

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA panel gives mixed vote on blood pressure devices

Drug repurposing or repositioning? The language matters

How to make AI work for medicine

23andMe had bad news about my health. I wish a person had delivered it

Biotech venture capitalists face new demands from investors

entertainment

Dewpoint Therapeutics lays off staff after losing partnerships

Appeals court upholds limits to abortion pill

Readout Newsletter: Merck, J&J, and long Covid

NIH director takes cautious approach to Biden drug pricing priority

Departing Stanford president retracts two papers

How a symptom of dementia informs our understanding of creativity

Wikipedia

knowledge

leisure time

Wikipedia